Inactive Instrument

MTL Cannabis Corp.

MTLC

CA5539261068

Healthcare Facilities & Services

Delayed Canadian Securities Exchange Other stock markets 09:30:00 2026-03-13 am EDT			5-day change	1st Jan Change
0.5700 ^CAD	+1.79%		+1.79%	-12.31%

Mar. 16	Canopy Growth Corporation completed the acquisition of MTL Cannabis Corp..	CI
Mar. 16	Canopy Growth Completes Acquisition of MTL Cannabis	MT

Mtl Cannabis obtains final court approval for plan of arrangement with Canopy Growth

Published on 02/23/2026 at 05:02 pm EST

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about MTL Cannabis Corp.

Mar. 16	Canopy Growth Corporation completed the acquisition of MTL Cannabis Corp..	CI
Mar. 16	Canopy Growth Completes Acquisition of MTL Cannabis	MT
Mar. 16	Canopy Growth completes acquisition of MTL Cannabis creating Canada's leading medical cannabis business by revenue	RE
Feb. 27	MTL Cannabis Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
Feb. 23	Mtl Cannabis obtains final court approval for plan of arrangement with Canopy Growth	RE
Feb. 23	MTL Cannabis Brief: Says Obtained Final Court Approval for Plan of Arrangement with Canopy Growth	MT
Feb. 18	Canopy Growth Brief: Announced MTL Cannabis Shareholder Approval of Acquisition	MT
Dec. 15	Canopy Growth Corporation entered into an arrangement agreement to acquire MTL Cannabis Corp. for approximately CAD 120 million.	CI
Dec. 15	Canopy Growth Up Near 7% In US Premarket As Moves To Acquire MTL Cannabis	MT
Dec. 15	Canopy Growth to acquire MTL Cannabis	RE
Dec. 15	Canopy Growth Brief: Says Transaction "Expected To Create Canada's Leading Medical Cannabis Business and Enhance Capacity To Serve Growing International Demand"	MT
Dec. 15	Canopy Growth Brief: Moving To Acquire MTL Cannabis	MT
Nov. 28	MTL Cannabis Corp. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-09-19	Mtl Cannabis announces closing of $2 million brokered life offering	RE
25-09-19	MTL Cannabis Brief: Closes $2 Million Brokered LIFE Offering Led by Centurion One Capital	MT

MTL Cannabis Corp. is focused on crafting cannabis products, including lines of dried flower, pre-rolls and hash marketed. The Company, through its subsidiaries, is engaged in the cultivation and production of cannabis products for recreational and medical purposes in Canada. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions. Its wholly owned subsidiaries include Montreal Medical Cannabis Inc. (Montreal Cannabis), Abba Medix Corp. (Abba), Canada House Clinics Inc. (CHC), and IsoCanMed Inc. (ICM). Montreal Medical is a licensed producer operating from a 57,000 sq ft licensed indoor growing facility in Pointe Claire, Quebec. Abba is a licensed producer in Pickering, Ontario that operates a medical cannabis marketplace. CHC is operating clinics across Canada. ICM is a licensed producer in Louiseville, Quebec growing indoor cannabis in its 64,000 sq. ft. production facility.

Employees

127

Sector

Healthcare Facilities & Services

More about the company